4.6 Article

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Christine Lonjou et al.

PHARMACOGENETICS AND GENOMICS (2008)

Article Biotechnology & Applied Microbiology

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

Shuen-Lu Hung et al.

PHARMACOGENETICS AND GENOMICS (2006)

Article Health Care Sciences & Services

A new method for assessing drug causation provided agreement with experts' judgment

Y Arimone et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)

Article Dermatology

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis

A Nassif et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)

Review Public, Environmental & Occupational Health

Spontaneous adverse event signaling methods: Classification and use with health care treatment products

JA Clark et al.

EPIDEMIOLOGIC REVIEWS (2001)

Article Medicine, General & Internal

Epidemiological assessment of drug-induced disease

DW Kaufman et al.

LANCET (2000)

Article Dermatology

Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis

P Paquet et al.

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2000)